<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="14017" end="14022" sStart="13953" offset="64" sid="r7.1.use.v.0830" wn="1" wnkey="use%2:34:01::" text="Therefore, ADGE microarray could provide a platform for using 160-200 fold less total RNA than regular microarray (which generally requires 20 ?g of total RNA)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="15492" end="15503" sStart="null" offset="102" sid="null" wn="1" wnkey="recommend%2:32:01::" text="The use of aminoallyl-dUTP in PCR amplification of the hybridized DNA template is not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="15492" end="15503" sStart="null" offset="102" sid="null" wn="1" wnkey="recommend%2:32:01::" text="The use of aminoallyl-dUTP in PCR amplification of the hybridized DNA template is not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="14425" end="14436" sStart="null" offset="287" sid="r11.recommend.v.0401" wn="1" wnkey="recommend%2:32:01::" text="It is also comparable to other RNA amplification methods, such as antisense RNA amplification where 0.25 - 3.0 ?g of total RNA is required [ 14 ] and Amine-modified random primer where 1.0 ?g of total RNA is required [ 15 ] . 20-30 PCR cycles are recommended since too few cycles will reduce the difference between the exponentially amplified tester or control DNA and the linearly amplified hybrid DNA and too many cycles will saturate abundant genes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="15492" end="15503" sStart="null" offset="102" sid="r11.recommend.v.0093" wn="1" wnkey="recommend%2:32:01::" text="The use of aminoallyl-dUTP in PCR amplification of the hybridized DNA template is not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="15492" end="15503" sStart="null" offset="102" sid="null" wn="1" wnkey="recommend%2:32:01::" text="The use of aminoallyl-dUTP in PCR amplification of the hybridized DNA template is not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="15492" end="15503" sStart="null" offset="102" sid="r11.recommend.v.0093" wn="1" wnkey="recommend%2:32:01::" text="The use of aminoallyl-dUTP in PCR amplification of the hybridized DNA template is not recommended." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="33713" end="33717" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="33713" end="33717" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="33713" end="33717" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="33713" end="33717" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="33713" end="33717" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="6876" end="6881" sStart="null" offset="0" sid="null" wn="6" wnkey="power%1:10:00::" text="The magnification of &lt;b&gt;power&lt;/b&gt; function continued until the 6-fold input ratio." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2164-4-28.anc" start="20007" end="20011" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" text="PP2 is a serine/threonine phosphatase which dephosphorylates JNK during inflammatory cell signaling [ 19 ] , while MKP5 is a member of the dual specificity phosphatase family which selectively dephosphorylates stress activated MAP kinases including JNK [ 20 ] . The overexpression of these two phosphatases might contribute in &lt;b&gt;part&lt;/b&gt; to the resistance of HL60/TLK286 by impairing the activity of JNK." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="4041" end="4047" sStart="null" offset="101" sid="r9.level.n.0381" wn="1" wnkey="level%1:07:00::" text="Cellular response to chronic TLK286 exposure included a two-fold decrease in GSTP1-1 protein levels, confirming a GSTP1-1 mediated mechanism of activation [ 7 ] . Mouse embryo fibroblast cells from GSTP1-1 deficient animals elevated the expression of signal-regulated kinases ERK1/ERK2 and reduced the doubling time of cell proliferation [ 8 ] . That paper also found that a clone of HL60 cells resistant to TLK199, an inhibitor of GSTP1-1, has been shown to have elevated activities of c-Jun NH 2 -terminal kinase (JNK) and ERK1/ERK2." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="729" end="734" sStart="null" offset="485" sid="r9.level.n.0125" wn="1" wnkey="level%1:07:00::" text="DNA microarray technologies are designed to reveal gene expression profiles by simultaneously detecting the expression levels on a genomic scale [ 1 2 ] . They are now used to profile gene expression in a variety of model systems, such as antioxidant response [ 3 ] and tumor staging [ 4 ] . However, the hybridization based approach suffers from limitations including, low sensitivity for genes with small changes of expression level, limited accuracy with potential for high experimental error [ 5 ] and necessity for a large amount of biological starting material." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="5201" end="5205" sStart="null" offset="185" sid="r10.high.j.0559" wn="1" wnkey="high%3:00:02::" text="The results show that ADGE microarray improves the sensitivity and fidelity of detection and reduces the requirement for starting material while maintaining the high throughput of regular microarray." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="21179" end="21183" sStart="null" offset="211" sid="r10.high.j.0520" wn="1" wnkey="high%3:00:02::" text="It magnified the ratios of differential gene expression in power function, improved detection sensitivity and fidelity and reduced the requirement for starting material while maintaining high throughput." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="7603" end="7607" sStart="null" offset="191" sid="r10.high.j.0274" wn="1" wnkey="high%3:00:02::" text="The MA plot of ADGE microarray has wider upward and downward distribution from the central area than that of regular microarray, particularly for the spots with high intensity (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="11152" end="11161" sStart="null" offset="27" sid="r11.function.n.0952" wn="2" wnkey="function%1:07:00::" text="Among the 93 genes, 12 had functions related to cell proliferation and kinase pathways (Table 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="6465" end="6473" sStart="null" offset="162" sid="r11.function.n.0625" wn="1" wnkey="function%1:24:00::" text="This relationship is close to the theoretical one of quadratic magnification y = x 2. Therefore, the ratios were magnified in power function within this low range." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="12082" end="12090" sStart="null" offset="29" sid="r11.function.n.0419" wn="2" wnkey="function%1:07:00::" text="The magnification of a power function was found up to a 6-fold input ratio or 30-fold detected ratio." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="8680" end="8684" sStart="null" offset="142" sid="null" wn="2147483645" wnkey="null" text="However, with ADGE microarray, there were 63 genes &gt;4 fold up-regulated, 220 genes 2-4 fold up-regulated, 92 genes 2-4 fold down-regulated and 14 genes &gt;4 down-regulated." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="1818" end="1822" sStart="null" offset="47" sid="null" wn="2147483645" wnkey="null" text="For example, for a gene up-regulated 2-fold in tester over control, the formula is (a + 2b)(a' + 2b') = aa' + 4bb' + 2a'b + 2ab'." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="8064" end="8068" sStart="null" offset="185" sid="r9.fold.v.0677" wn="5" wnkey="fold%2:30:10::" text="In contrast, with regular microarray, 227 and 244 of 10,000 genes were detected at 2-4 fold up- and down-regulated, respectively; 10 and 30 genes at &gt;4 fold up- and down-regulated, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="12119" end="12123" sStart="null" offset="66" sid="r9.fold.v.0365" wn="2147483645" wnkey="null" text="The magnification of a power function was found up to a 6-fold input ratio or 30-fold detected ratio." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-4-28.anc" start="8605" end="8609" sStart="null" offset="67" sid="r9.fold.v.0185" wn="5" wnkey="fold%2:30:10::" text="However, with ADGE microarray, there were 63 genes &gt;4 fold up-regulated, 220 genes 2-4 fold up-regulated, 92 genes 2-4 fold down-regulated and 14 genes &gt;4 down-regulated." />
  </sentences>
</list>